Microbiology News : clinical

Marketing Microbiology Products
rapidmicrobiology.com is the marketing solution for global microbiology brands - uniquely focused on connecting buyers of routine microbiology laboratory products with suppliers.Get your 2021 campaign started now and enjoy the benefits. more...
New products for SARS-CoV-2 the coronavirus that causes COVID-19
This week: Low-cost nanopore sequencing COVID-19 saliva-based test; informatics for public health reporting; rapid antigen test results in 15 minutes with dipstick method and Opentrons launch a new HEPA filter for its OT-2 Robot.  more...
HEPA filter for OT-2 robot
Opentrons' robotics have enabled high-throughput COVID-19 testing during the pandemic, and a new HEPA filtration unit for their OT-2 robot decreases the risk of contamination for sensitive wet lab applications like PCR and DNA / RNA amplification without need for a cleanroom. more...
Biologics testing
PathoQuest is expanding and upgrading its Paris' site with a €500K support from Paris Île-de-France Region. Next year will see them offering cutting-edge and high-capacity NGS QC testing services for rapid development and release of biologics at a GMP grade. more...
Rapid Antigen SARS-CoV-2 Test for Latin America
The government of Columbia has recently performed a clinical evaluation of the Edinburgh Genetics ActivXpress+ COVID-19 Antigen Complete Testing Kit with a sample size of over 140 samples. Results show a sensitivity of 90.60% and specificity of 100%. more...
Rapid Antigen test for SARS-CoV-2 the coronavirus that causes COVID-19
Developed in Europe by ProGnosis Biotech, the Rapid Test Ag 2019-nCov detects the SARS-CoV-2 antigen in nasopharyngeal swab specimens in 15 mins. High Sensitivity (95.56%) & Specificity (99.56%). The test has received a CE-IVD mark. more...
Nanopore sequencing diagnostic for SARS-CoV-2
Angstrom Bio has launched a nanopore sequencing saliva-based COVID-19 diagnostic that can provide low-cost, high-frequency and highly accurate testing to "nearly any organization". A SARS-CoV-2 and influenza test is also to be rolled out soon.   more...
Informatics solution for sars-cov-2 data
BD announces streamlined reporting capabilities for COVID-19 data through BD Synapsys™ 3.84 Informatics Solution that simplifies mandatory public health reporting for customers using BD Veritor™ and BD MAX™ systems. more...
Recombinant Spike Protein of Mink Strain
Sino Biological has launched a recombinant Y453F RBD protein, the mutation in SARS-CoV-2 that infected mink and workers at a farm in Denmark recently. This protein adds to Sino's large collection of proteins for antibody and vaccine research.  more...

ACT Gives Priorclave Green Credentials

24 Nov 2020 | F&BWCPCCM

Autoclaves
Accountability, consistency and transparency; the ACT program has given one of it's first eco-labels to Priorclave's cylindrcal chambers research-grade autoclaves for its efficiency in water use and energy.  more...
New products for sars cov 2 the coronavirus that causes COVID-19
This week: New T-Cell detection test for previous SARS-CoV-2 infection is developed through Microsoft and biotech firm; ECDC say buffers not reliable for rapid antigen tests and FDA OK molecular-based SARS-CoV-2 test for at-home-testing. more...
EU ecdc recommends rapid antigen tests for covid 19
The ECDC has revised its recommendations for rapid antigen testing in a new document that provides independent evaluations of several rapid antigen tests on the market along with requirements labs must adhere to.  more...
Home testing for SARS-CoV-2
The US FDA has authorized the first prescription COVID-19 molecular test that can be performed entirely at-home. The test fits into the palm of your hand and uses real-time LAMP technology to give a result in just 11 minutes.  more...
CRISPR FELUDA SARS COV 2 Test for COVID 19 Diagnosis
Tata Group has begun distributing its Feluda COVID-19 test to labs across India. The CRISPR-based test utilizes a specially adapted Cas9 protein transcription, and a result is read on a dipstick placed into the CRISPR mixture after amplification of the viral material.  more...
Point of care immunoassay development
Cytiva (Formerly GE Healthcare) has started a new diagnostic test development and support service for point-of-care diagnostic developers to increase speed to market of new tests through infrastructure, expertise and consultation for immunoassay development. more...
T-cell detection for covid 19 past infection
A new clinical diagnostic test that measures the T-cell response in SARS-CoV-2 infected individuals that can provide a complete picture of the duration of immunity to the virus following an infection or administration of a vaccine will be released this fall.  more...
New products for sars cov 2 the coronavirus that causes COVID-19
A new buyer's guide for rapid antigen/POC tests; German Airports automate testing workflow; Precision Genetics prefer Isohelix saliva collection device; ELISA test to measure antibody response for vaccine research and portable device analyzes swabs give positive results in 2 minutes.  more...
Rapid Antigen and Near Patient Testing for SARS CoV 2
This buyers guide summarizes the range of COVID-19 rapid tests available on the world market for near-patient, screening and serial testing at workplaces, airports and schools. It also gives details of each supplier and provides a means to contact them. ​ more...
ELISA Test for SARS Cov 2 IgG antibody to spike protein
EUROIMMUN has launched the Anti-SARS-CoV-2 QuantiVac™ ELISA (IgG) to quantify IgG antibodies against the SARS-CoV-2 S1 antigen. The assay is CE-marked, and the company plans to file for US FDA-EUA. more...
Portable SARS CoV 2 Antigen test Takes Two Minutes for Positive
QIAGEN has begun distributing its QIAreach™ SARS-CoV-2 Antigen Test for use on digital eHub and eStick system developed by Ellume. The portable device can give a positive result in as little as 2 minutes and a negative in 15 minutes. more...
Saliva collection device for SARS CoV 2 testing
The new GeneFiX™ Saliva RNA Collection Device from Isohelix has been validated by Precision Genomics and is now its preferred method for saliva collection as part of its FDA-EUA SARS-CoV-2 testing portfolio.  more...
high-throughput antigen testing at german airports
Through a partnership with Centogene and Fujirebio, Lufthansa airports in Germany are expandng its antigen testing program for its passengers. Fujirebio will provide Centogene labs with a steady supply of its Lumipulse G SARS-CoV-2 Ag to run on the fully-automated LUMIPULSE G1200 system. more...
New Products for COVID 19 Testing
This week: A subgenomic RNA test that detects only viable SARS-CoV-2 material; new lateral-flow antibody test development service; several case-studies on the benefits of SARS-CoV-2 surveillance in wastewater and the first rapid antigen surface test.  more...
Antimicrobial Resistance Detection
In this special focus on HAIs and AMR, we bring you the latest screening, identification, diagnostic and surveillance kits to give your clinical lab the power to control and treat antimicrobial-resistant infections.   more...
Asp galactomannan lateral flow kit
IMMY sõna Aspergillus Galactomannan Lateral Flow Assay is recommended by the European Confederation of Medical Microbiology (ECMM) as a screening device in COVID ventilated patients. more...
Designed to improve efficiency, the AFYS3G Recapper for Screw Cap Tubes can be used as a stand-alone instrument or be simply integrated into a fully automated laboratory environment. more...
sgRNA profiling in SARS CoV 2 virus that causes covid 19
The new DeepMARK™ NGS assay for profiling SARS-CoV-2 genomic and subgenomic RNA in clinical specimens has compelling use cases for rapid public health response, research, and vaccine development. more...
Automated reading and CLSI and EUCAST interpretaion of clinical and qc tests
BIOMIC V3 is an open system utilizing digital imaging to automate the reading and CLSI/EUCAST interpretation of AST-ID-QC from various manufacturers. BIOMIC V3 is designed and manufactured by Giles Scientific in California. more...
Fast Carbapenamase Resistant Enterobacterales CRE detection with rapid lateral flow
The CDC classifies HAIs as “Winnable Battles” and commits surveillance to reduce the incidence of HAIs and improve patient outcome. The emergence of Carbapenem-Resistant Enterobacterales (CRE) is an urgent threat, requiring immediate action. more...
Automated MRSA Plate assessment
LBT Innovations has licensed its AI-powered MRSA plate screening and interpretation software to the largest clinical laboratory group in Germany. The APAS independence system with the MRSA Analysis Module can do thousands of plates per day.  more...